GMED
Income statement / Annual
Last year (2024), Globus Medical, Inc.'s total revenue was $2.52 B,
an increase of 60.62% from the previous year.
In 2024, Globus Medical, Inc.'s net income was $102.98 M.
See Globus Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$2.52 B |
$1.57 B |
$1.02 B |
$958.10 M |
$789.04 M |
$785.37 M |
$712.97 M |
$635.98 M |
$563.99 M |
$544.75 M |
| Cost of Revenue |
$1.04 B
|
$548.17 M
|
$263.73 M
|
$239.22 M
|
$217.46 M
|
$179.98 M
|
$159.41 M
|
$150.45 M
|
$134.71 M
|
$132.80 M
|
| Gross Profit |
$1.48 B
|
$1.02 B
|
$759.12 M
|
$718.88 M
|
$571.58 M
|
$605.39 M
|
$553.56 M
|
$485.52 M
|
$429.29 M
|
$411.95 M
|
| Gross Profit Ratio |
0.59
|
0.65
|
0.74
|
0.75
|
0.72
|
0.77
|
0.78
|
0.76
|
0.76
|
0.76
|
| Research and Development Expenses |
$163.75 M
|
$124.01 M
|
$73.02 M
|
$97.35 M
|
$84.52 M
|
$60.07 M
|
$55.50 M
|
$43.68 M
|
$44.53 M
|
$36.98 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$311.59 M
|
$267.82 M
|
$222.16 M
|
$214.01 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$981.05 M
|
$643.41 M
|
$432.12 M
|
$408.15 M
|
$354.76 M
|
$354.76 M
|
$311.59 M
|
$267.82 M
|
$222.16 M
|
$214.01 M
|
| Other Expenses |
$173.08 M
|
$119.74 M
|
$17.74 M
|
$18.53 M
|
$16.83 M
|
$13.81 M
|
$19.28 M
|
$8.09 M
|
$3.14 M
|
$583,000.00
|
| Operating Expenses |
$1.32 B
|
$887.16 M
|
$522.87 M
|
$524.02 M
|
$456.11 M
|
$428.64 M
|
$376.68 M
|
$319.41 M
|
$270.17 M
|
$251.00 M
|
| Cost And Expenses |
$2.35 B
|
$1.44 B
|
$786.59 M
|
$763.24 M
|
$673.57 M
|
$608.61 M
|
$536.09 M
|
$469.86 M
|
$404.87 M
|
$383.80 M
|
| Interest Income |
$0.00
|
$0.00
|
$14.23 M
|
$9.30 M
|
$13.95 M
|
$17.41 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$14.23 M
|
$9.30 M
|
$13.95 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$254.02 M
|
$144.73 M
|
$68.25 M
|
$69.87 M
|
$62.87 M
|
$52.73 M
|
$41.63 M
|
$42.07 M
|
$38.77 M
|
$24.08 M
|
| EBITDA |
$473.73 M |
$346.58 M |
$304.50 M |
$250.28 M |
$178.35 M |
$242.68 M |
$218.51 M |
$208.70 M |
$201.89 M |
$188.39 M |
| EBITDA Ratio |
0.19
|
0.22
|
0.31
|
0.3
|
0.23
|
0.29
|
0.32
|
0.33
|
0.36
|
0.32
|
| Operating Income Ratio |
0.07
|
0.08
|
0.22
|
0.18
|
0.14
|
0.22
|
0.24
|
0.25
|
0.27
|
0.32
|
| Total Other Income/Expenses Net |
-$45.27 M
|
$32.25 M
|
$15.07 M
|
$8.45 M
|
$14.47 M
|
$17.96 M
|
$19.28 M
|
$8.09 M
|
$3.14 M
|
$583,000.00
|
| Income Before Tax |
$120.72 M
|
$165.39 M
|
$243.02 M
|
$180.41 M
|
$125.90 M
|
$189.95 M
|
$188.61 M
|
$169.93 M
|
$157.28 M
|
$172.81 M
|
| Income Before Tax Ratio |
0.05
|
0.11
|
0.24
|
0.19
|
0.16
|
0.24
|
0.26
|
0.27
|
0.28
|
0.32
|
| Income Tax Expense |
$17.74 M
|
$42.52 M
|
$52.85 M
|
$31.22 M
|
$23.61 M
|
$34.74 M
|
$32.13 M
|
$62.58 M
|
$52.94 M
|
$60.02 M
|
| Net Income |
$102.98 M
|
$122.87 M
|
$190.17 M
|
$149.19 M
|
$102.29 M
|
$155.21 M
|
$156.47 M
|
$107.35 M
|
$104.34 M
|
$112.78 M
|
| Net Income Ratio |
0.04
|
0.08
|
0.19
|
0.16
|
0.13
|
0.2
|
0.22
|
0.17
|
0.19
|
0.21
|
| EPS |
0.76 |
1.09 |
1.89 |
1.48 |
1.04 |
1.57 |
1.6 |
1.12 |
1.09 |
1.19 |
| EPS Diluted |
0.75 |
1.07 |
1.85 |
1.44 |
1.01 |
1.52 |
1.54 |
1.1 |
1.08 |
1.17 |
| Weighted Average Shares Out |
$135.73 M
|
$113.09 M
|
$100.47 M
|
$100.73 M
|
$98.58 M
|
$99.15 M
|
$97.88 M
|
$96.24 M
|
$95.65 M
|
$95.05 M
|
| Weighted Average Shares Out Diluted |
$137.86 M
|
$114.63 M
|
$102.64 M
|
$103.62 M
|
$100.97 M
|
$102.00 M
|
$101.32 M
|
$97.89 M
|
$96.43 M
|
$96.07 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
